logo

For the Inventor, By the Inventor

Gainesville, FL, United States of America

Raymond J Bergeron, Jr

This inventor holds 101 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Iron Chelation Therapy (CPC class 514374). Top assignees: University of Florida Research Foundation Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Sunpharm Corporation. Active years: 1985-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond J Bergeron, Jr. Retrieved from https://idiyas.com/inventor/raymond-j-bergeron-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 101 

% Patents Active = 87.1

 

Average Co-Inventor Count = 1.0

ph-index = 14

Forward Citations = 796(Granted Patents)

Forward Citations (Not Self Cited) = 430(Dec 10, 2025)


Inventors with similar research interests:


    Company Filing History:

    goldMedal100 out of 3,058 
     
    University of Florida Research Foundation Inc.
     patents
    silverMedal2 out of 3,699 
     
    The United States of America, as Represented by the Secretary, Department of Health and Human Services
     patents
    bronzeMedal1 out of 1 
     
    Sunpharm Corporation
     patent
    4. 2 out of 834,601 
    Other
     patents
    where one patent can have more than one assignee

    Years Active: 1985-2024

    Loading Chart...
    Loading Chart...
    Areas of Expertise:
    Iron Binding Agents
    Desferrithiocin Analogs
    Siderophore Conjugates
    Thiazoline Acid Derivatives
    Polyamines
    Anti-Hypertensive Composition
    Metabolically Programmed Chelators
    Synthetic Hypusine Peptides
    Pharmaceutical Compositions
    Immunogenic Compositions
    Anti-Neoplastic Derivatives
    Gastrointestinal Treatments
    101 patents (USPTO):Explore Patents
    1. 11931346 - Uses of 4′-desferrithiocin analogs (2024-03-19),
    2. 10570104 - Metabolically programmed metal chelators and uses thereof (2020-02-25),
    3. 10010535 - Desferrithiocin analogs and uses thereof (2018-07-03),
    4. 9994535 - Desferrithiocin polyether analogues (2018-06-12),
    5. 9730917 - Desferrithiocin polyether analogues (2017-08-15),
    6. 9567309 - Desferrithiocin polyether analogues (2017-02-14),
    7. 9174948 - Desferrithiocin polyether analogues (2015-11-03),
    8. 9125950 - Siderophore conjugate immunogenic compositions and vaccines (2015-09-08),
    9. 9096553 - Desferrithiocin polyether analogues (2015-08-04),
    10. 8834890 - Siderophore conjugate immunogenic compositions and vaccines (2014-09-16),
    11. 8722899 - Desferrithiocin polyether analogues (2014-05-13),
    12. 8604216 - Desferrithiocin derivatives and methods of use thereof (2013-12-10),
    13. 8324397 - Desferrithiocin polyether analogues (2012-12-04),
    14. 8278458 - Desferrithiocin polyether analogues (2012-10-02),
    15. 8008502 - Thiazoline acid derivatives (2011-08-30),

    Certainly! Here is the article about inventor Raymond J Bergeron, Jr:

    Title: Raymond J Bergeron, Jr: A Visionary in the World of Inventions

    Introduction:

    Raymond J Bergeron, Jr, based in Gainesville, FL, is a true visionary in the realm of innovations. With a remarkable drive for creating solutions to complex challenges, he has made a significant impact in the field of inventions.

    Latest Patents:

    Raymond J Bergeron, Jr holds an impressive 101 patents. Among his latest patents are groundbreaking inventions including Uses of 4′-desferrithiocin analogs and Metabolically programmed metal chelators, which herald new possibilities in treating various diseases and conditions associated with reactive oxygen species and metal overload.

    Career Highlights:

    Having worked with esteemed institutions like the University of Florida Research Foundation, Incorporated and the University of Florida, Raymond J Bergeron, Jr has showcased his expertise in pushing the boundaries of innovation. His relentless pursuit of excellence has resulted in a diverse portfolio of patents that address critical health issues and diseases.

    Collaborations:

    Throughout his career, Raymond J Bergeron, Jr has collaborated with notable experts in the field. Some of his esteemed coworkers include Charles A Sninsky and Stefan Borg, who have contributed to the success of his innovative projects.

    Conclusion:

    In conclusion, Raymond J Bergeron, Jr's passion for innovation and his dedication to finding solutions to challenging problems have cemented his position as a true visionary in the world of inventions. His groundbreaking patents stand as a testament to his ingenuity and commitment to making a positive impact on society.

    Is there anything else you would like to know or explore about innovations, inventions, inventors, patent attorneys, assignees, or patents?

    Profile summary based on public USPTO records.
    Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
    Loading…